COVID-19 with rapid progression to hypoxemia likely due to imbalance
between ventilation and blood flow: A case report
AbstractWe experienced a case of COVID-19 with hypoxia, which was presumed to be
due to the development of ventilation and blood flow imbalance by
pulmonary intravascular coagulopathy or hypoxic pulmonary
vasoconstriction. Early, short-term combination therapy with remdesivir,
nafamostat mesilate and low-dose dexamethasone was extremely effective.